Tick-Transmitted Diseases in Dogs: Anaplasmosis, Ehrlichiosis, and Lyme Disease

Introduction

Tick-transmitted diseases represent a significant and growing burden in canine medicine worldwide [1, 2, 3]. Among the most clinically relevant are anaplasmosis (caused by Anaplasma phagocytophilum and Anaplasma platys), ehrlichiosis (caused primarily by Ehrlichia canis, Ehrlichia chaffeensis, and Ehrlichia ewingii), and Lyme disease (caused by Borrelia burgdorferi sensu stricto) [4, 5, 6]. These obligate intracellular bacteria and spirochetes are transmitted by ixodid ticks of the genera Ixodes, Rhipicephalus, and Amblyomma [7, 8, 9]. The geographic distribution of each pathogen is largely determined by the range of its competent tick vector and the presence of suitable reservoir hosts [10, 11]. Understanding the biological, clinical, and diagnostic nuances of these infections is essential for veterinary practitioners in endemic regions [12, 11]. This article provides a detailed review of the three major dog tick transmitted diseases with emphasis on molecular pathogenesis, diagnostic algorithms, and evidence-based management.

Epidemiology and Vector Ecology

The epidemiology of canine anaplasmosis, ehrlichiosis, and Lyme disease reflects complex interactions between tick vectors, vertebrate reservoirs, and environmental factors [13, 10]. Anaplasma phagocytophilum is transmitted by Ixodes spp. ticks and has been documented in North America, Europe, and Asia [14, 15, 16]. Seroprevalence studies in dogs from the United States have identified associations with geographic region, season, and tick exposure [10]. Anaplasma platys, the agent of cyclic thrombocytopenia, is transmitted by Rhipicephalus sanguineus and has a global distribution in tropical and subtropical regions [17, 18, 19].

Ehrlichia canis is also vectored by R. sanguineus and is endemic in many parts of the Americas, Africa, Asia, and southern Europe [2, 3, 20, 21, 19]. Ehrlichia chaffeensis and E. ewingii are primarily transmitted by Amblyomma americanum in the United States [22, 23, 24]. Molecular surveys using multiplex PCR have demonstrated co-infections with multiple tick-borne pathogens in individual dogs, complicating clinical diagnosis [2, 17, 7].

Borrelia burgdorferi sensu lato is maintained in enzootic cycles involving Ixodes ticks and small mammal reservoirs [25, 26]. Canine seroprevalence is highest in regions where Ixodes scapularis and Ixodes pacificus are established, including the northeastern, mid-Atlantic, and upper Midwestern United States, as well as parts of Europe and Asia [3, 21, 27, 28]. In Australia, canine sentinel studies have not confirmed endemic Lyme borreliosis, suggesting the absence of competent enzootic transmission [26].

Table 1 summarizes the primary pathogens, vectors, and geographic distributions.

Table 1. Major tick-transmitted pathogens of dogs: vectors and distribution.

Pathogen Biology and Life Cycle

All three disease agents are transmitted during tick feeding. Anaplasma and Ehrlichia species are obligate intracellular Gram-negative bacteria that replicate within membrane-bound vacuoles in host cells [4, 32]. A. phagocytophilum preferentially infects neutrophils, while A. platys targets platelets [14]. E. canis infects monocytes and macrophages, and E. chaffeensis also targets mononuclear phagocytes [29, 22, 30]. E. ewingii infects granulocytes [24]. The genomes of these bacteria are reduced, reflecting their dependence on host cell machinery [32].

Borrelia burgdorferi is a motile spirochete that resides in the tick midgut and migrates to the salivary glands during feeding [31]. In the canine host, B. burgdorferi disseminates through connective tissues and can evade immune clearance through antigenic variation [31, 33].

Persistence in the vertebrate host is a hallmark of these infections. E. chaffeensis employs multiple genes for immune evasion and persistent infection, as demonstrated by random mutagenesis studies [30]. Genes critical for persistence in the vertebrate host are not necessarily required for growth in the tick vector, indicating distinct selective pressures [22]. Live attenuated vaccines using targeted gene deletions have shown promise in inducing protective CD4+ T cell responses in dogs [29, 34]. Similarly, outer membrane protein (OMP-1B) and type IV secretion system (VirB2-4) vaccines have been evaluated for protection against tick-transmitted E. chaffeensis challenge [23].

Clinical Signs

Clinical manifestations of tick-transmitted diseases in dogs range from subclinical infection to severe, life-threatening illness [12]. The incubation period varies by pathogen and dose.

Anaplasmosis. Acute A. phagocytophilum infection typically presents with fever, lethargy, anorexia, and lameness due to polyarthritis [14, 15]. Thrombocytopenia is a consistent hematologic finding [14]. A. platys infection causes cyclic thrombocytopenia, with platelet counts dropping every 10–14 days; clinical signs are often mild but can include petechiae and epistaxis [17, 18].

Ehrlichiosis. Canine monocytic ehrlichiosis (CME) caused by E. canis progresses through acute, subclinical, and chronic phases [12]. The acute phase (1–4 weeks post-infection) features fever, lymphadenomegaly, and thrombocytopenia. The subclinical phase may last months to years. Chronic CME is characterized by pancytopenia, bleeding diathesis, and secondary infections [12]. E. chaffeensis and E. ewingii infections in dogs are less well characterized but can cause fever, polyarthritis, and thrombocytopenia [23, 24].

Lyme disease. Most dogs infected with B. burgdorferi remain asymptomatic [33]. A subset develops acute lameness, fever, and lymphadenopathy. A severe immune-mediated glomerulonephritis, termed Lyme nephritis, has been described in certain breeds (e.g., Labrador Retrievers, Rottweilers) and carries a poor prognosis [31, 33]. Neurologic signs are rare in dogs compared to humans [27].

Diagnostics

Accurate diagnosis relies on a combination of serologic and molecular methods, supported by hematologic and biochemical findings [2, 3, 28].

Serology. Detection of antibodies against A. phagocytophilum, E. canis, and B. burgdorferi is commonly performed using commercial ELISA kits that incorporate synthetic peptides such as the C6 peptide for B. burgdorferi [3, 31, 21]. Indirect immunofluorescence assays (IFA) are also used but require paired acute and convalescent samples for confirmation [27, 28]. Seroprevalence surveys have provided valuable epidemiologic data [13, 10].

Molecular detection. PCR assays targeting species-specific genes (e.g., 16S rRNA, groEL, p28 OMP genes) offer high sensitivity and specificity for active infection [2, 17, 18, 7, 15, 19]. Multiplex PCR panels can simultaneously detect Anaplasma, Ehrlichia, and Borrelia species [2]. Real-time PCR is increasingly used in reference laboratories.

Hematology and biochemistry. Thrombocytopenia is a hallmark of both anaplasmosis and ehrlichiosis [14, 12]. Pancytopenia suggests chronic E. canis infection. Proteinuria and azotemia may indicate Lyme nephritis [33].

Table 2 summarizes diagnostic approaches.

Table 2. Diagnostic methods for tick-transmitted diseases in dogs.

Treatment

Doxycycline is the cornerstone of therapy for anaplasmosis and ehrlichiosis [6, 12]. A standard course of 10–14 days is recommended for acute anaplasmosis; for ehrlichiosis, treatment may extend to 28 days or longer in chronic cases [12]. Tetracycline antibiotics are also effective [6]. Clinical improvement is usually rapid, but hematologic recovery may take weeks.

For Lyme disease, doxycycline (10 mg/kg q24h for 30 days) is the first-line agent [33]. Supportive care including fluid therapy and nephroprotective measures is indicated for dogs with protein-losing nephropathy [33]. The use of acaricides to prevent tick attachment is critical in endemic areas [35].

Prevention and Control

Prevention of tick-transmitted diseases relies primarily on consistent use of acaricides [1, 35]. Topical spot-on formulations, collars, and oral isoxazoline compounds have demonstrated efficacy in reducing tick infestation and pathogen transmission [35]. Integrated tick management includes environmental control and avoidance of tick habitats.

Vaccines for canine Lyme disease are available in some regions, but their efficacy is debated [33]. Experimental vaccines for E. chaffeensis using attenuated mutants or subunit antigens have shown promise in laboratory settings but are not yet commercially available [29, 23, 34]. No vaccines are currently licensed for canine anaplasmosis or ehrlichiosis.

The following Mermaid diagram outlines a diagnostic decision tree for a dog presenting with suspected tick-transmitted disease.

flowchart TD
    A[Clinical suspicion: fever, lameness, thrombocytopenia], > B{Point-of-care ELISA}
    B, >|Positive for Anaplasma/Ehrlichia| C[PCR confirmation and species identification]
    B, >|Positive for B. burgdorferi C6| D[Urinalysis for proteinuria]
    B, >|Negative| E[Consider other diagnoses: babesiosis, immune-mediated disease]
    C, > F[Initiate doxycycline therapy]
    D, > G[If proteinuric: manage Lyme nephritis]
    F, > H[Monitor clinical and hematologic response]
    G, > H

References

[1] Foley J, Backus L, López-Pérez AM. Focus on brown dog tick-transmitted Rocky Mountain spotted fever in dogs and people: shared threats and solutions. J Am Vet Med Assoc. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/39879657/

[2] Singh H, Padmaja M, Thomas AM, et al. Molecular Survey of Tick-Borne Haemoparasites of Dogs by Multiplex Polymerase Chain Reaction from Punjab, India. Acta Parasitol. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/39150582/

[3] Miranda EA, Han SW, Rim JM, et al. Serological evidence of Anaplasma spp., Borrelia burgdorferi and Ehrlichia canis in dogs from the Republic of Korea by rapid diagnostic test kits. J Vet Sci. 2022. URL: https://pubmed.ncbi.nlm.nih.gov/35187878/

[4] André MR. Diversity of Anaplasma and Ehrlichia/Neoehrlichia Agents in Terrestrial Wild Carnivores Worldwide: Implications for Human and Domestic Animal Health and Wildlife Conservation. Front Vet Sci. 2018. URL: https://pubmed.ncbi.nlm.nih.gov/30533417/

[5] Ferrell AM, Brinkerhoff RJ, Bernal J, et al. Ticks and tick-borne pathogens of dogs along an elevational and land-use gradient in Chiriquí province, Panamá. Exp Appl Acarol. 2017. URL: https://pubmed.ncbi.nlm.nih.gov/28417248/

[6] Zygner W, Wiśniewski M. [Tick-transmitted diseases which may threaten health of dogs in Poland]. Wiad Parazytol. 2006. URL: https://pubmed.ncbi.nlm.nih.gov/17120988/

[7] Campos-Calderón L, Ábrego-Sánchez L, Solórzano-Morales A, et al. Molecular detection and identification of Rickettsiales pathogens in dog ticks from Costa Rica. Ticks Tick Borne Dis. 2016. URL: https://pubmed.ncbi.nlm.nih.gov/27480409/

[8] Ndip LM, Ndip RN, Ndive VE, et al. Ehrlichia species in Rhipicephalus sanguineus ticks in Cameroon. Vector Borne Zoonotic Dis. 2007. URL: https://pubmed.ncbi.nlm.nih.gov/17627442/

[9] Torina A, Caracappa S. Dog tick-borne diseases in Sicily. Parassitologia. 2006. URL: https://pubmed.ncbi.nlm.nih.gov/16881419/

[10] McMahan CS, Wang D, Beall MJ, et al. Factors associated with Anaplasma spp. seroprevalence among dogs in the United States. Parasit Vectors. 2016. URL: https://pubmed.ncbi.nlm.nih.gov/27004557/

[11] Shaw SE, Binns SH, Birtles RJ, et al. Molecular evidence of tick-transmitted infections in dogs and cats in the United Kingdom. Vet Rec. 2005. URL: https://pubmed.ncbi.nlm.nih.gov/16299364/

[12] Foglia Manzillo V, Cappiello S, Oliva G. Tick-transmitted diseases in dogs: clinicopathological findings. Parassitologia. 2006. URL: https://pubmed.ncbi.nlm.nih.gov/16881415/

[13] Braff JC, Arguello-Marin A, Hanscom J, et al. Evaluation of Anaplasma spp. seroprevalence in dogs and association with incidence of human anaplasmosis. Vet Parasitol Reg Stud Reports. 2023. URL: https://pubmed.ncbi.nlm.nih.gov/37783532/

[14] De Arcangeli S, Balboni A, Serafini F, et al. Anaplasma phagocytophilum infection in thrombocytopenic dogs. Vet Ital. 2018. URL: https://pubmed.ncbi.nlm.nih.gov/29631317/

[15] Majláthová V, Majláth I, Víchová B, et al. Polymerase chain reaction confirmation of Babesia canis canis and Anaplasma phagocytophilum in dogs suspected of babesiosis in Slovakia. Vector Borne Zoonotic Dis. 2011. URL: https://pubmed.ncbi.nlm.nih.gov/21736486/

[16] Alberti A, Zobba R, Chessa B, et al. Equine and canine Anaplasma phagocytophilum strains isolated on the island of Sardinia (Italy) are phylogenetically related to pathogenic strains from the United States. Appl Environ Microbiol. 2005. URL: https://pubmed.ncbi.nlm.nih.gov

[17] Alhassan A, Hove P, Sharma B, et al. Molecular detection and characterization of Anaplasma platys and Ehrlichia canis in dogs from the Caribbean. Ticks Tick Borne Dis. 2021. URL: https://pubmed.ncbi.nlm.nih.gov/33865177/

[18] Pesapane R, Foley J, Thomas R, et al. Molecular detection and characterization of Anaplasma platys and Ehrlichia canis in dogs from northern Colombia. Vet Microbiol. 2019. URL: https://pubmed.ncbi.nlm.nih.gov/31176406/

[19] Cardoso L, Tuna J, Vieira L, et al. Molecular detection of Anaplasma platys and Ehrlichia canis in dogs from the North of Portugal. Vet J. 2010. URL: https://pubmed.ncbi.nlm.nih.gov/19056304/

[20] Vieira FT, Acosta ICL, Martins TF, et al. Tick-borne infections in dogs and horses in the state of Espírito Santo, Southeast Brazil. Vet Parasitol. 2018. URL: https://pubmed.ncbi.nlm.nih.gov/29279085/

[21] Movilla R, García C, Siebert S, et al. Countrywide serological evaluation of canine prevalence for Anaplasma spp., Borrelia burgdorferi (sensu lato), Dirofilaria immitis and Ehrlichia canis in Mexico. Parasit Vectors. 2016. URL: https://pubmed.ncbi.nlm.nih.gov/27474020/

[22] Jaworski DC, Wang Y, Nair A, et al. Multiple Ehrlichia chaffeensis genes critical for persistent infection in a vertebrate host are identified as nonessential for its growth in the tick vector; Amblyomma americanum. Front Cell Infect Microbiol. 2023. URL: https://pubmed.ncbi.nlm.nih.gov/37457955/

[23] Budachetri K, Lin M, Chien RC, et al. Efficacy and Immune Correlates of OMP-1B and VirB2-4 Vaccines for Protection of Dogs from Tick Transmission of Ehrlichia chaffeensis. mBio. 2022. URL: https://pubmed.ncbi.nlm.nih.gov/36342170/

[24] Zhang C, Xiong Q, Kikuchi T, et al. Identification of 19 polymorphic major outer membrane protein genes and their immunogenic peptides in Ehrlichia ewingii for use in a serodiagnostic assay. Clin Vaccine Immunol. 2008. URL: https://pubmed.ncbi.nlm.nih.gov/18094116/

[25] Ajaj EA, Al-Jumaa ZM. Molecular detection of Spirochetes and Borrelia burgdorferi in stray dogs of Nineveh province, Iraq. Open Vet J. 2023. URL: https://pubmed.ncbi.nlm.nih.gov/38027409/

[26] Irwin PJ, Robertson ID, Westman ME, et al. Searching for Lyme borreliosis in Australia: results of a canine sentinel study. Parasit Vectors. 2017. URL: https://pubmed.ncbi.nlm.nih.gov/28285585/

[27] Jäderlund KH, Egenvall A, Bergström K, et al. Seroprevalence of Borrelia burgdorferi sensu lato and Anaplasma phagocytophilum in dogs with neurological signs. Vet Rec. 2007. URL: https://pubmed.ncbi.nlm.nih.gov/17575245/

[28] Gary AT, Webb JA, Hegarty BC, et al. The low seroprevalence of tick-transmitted agents of disease in dogs from southern Ontario and Quebec. Can Vet J. 2006. URL: https://pubmed.ncbi.nlm.nih.gov/17217089/

[29] Madesh S, McGill J, Jaworski DC, et al. Prolonged immune response to tick-borne Ehrlichia chaffeensis infection using a genetically modified live vaccine. Vaccine. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/39826432/

[30] Wang Y, Nair ADS, Alhassan A, et al. Multiple Ehrlichia chaffeensis Genes Critical for Its Persistent Infection in a Vertebrate Host Are Identified by Random Mutagenesis Coupled with In Vivo Infection Assessment. Infect Immun. 2020. URL: https://pubmed.ncbi.nlm.nih.gov/32747600/

[31] Hatke AL, Green DR, Stasiak K, et al. Antibody profiling of a Borreliella burgdorferi (Lyme disease) C6 antibody positive, symptomatic Rottweiler and her pups. Vet J. 2020. URL: https://pubmed.ncbi.nlm.nih.gov/32792093/

[32] Mavromatis K, Doyle CK, Lykidis A, et al. The genome of the obligately intracellular bacterium Ehrlichia canis reveals themes of complex membrane structure and immune evasion strategies. J Bacteriol. 2006. URL: https://pubmed.ncbi.nlm.nih.gov/16707693/

[33] Gerber B, Eichenberger S, Haug K, et al. [The dilemma with Lyme borreliosis in the dog with particular consideration of "Lyme nephritis"]. Schweiz Arch Tierheilkd. 2009. URL: https://pubmed.ncbi.nlm.nih.gov/19780008/

[34] McGill JL, Nair AD, Cheng C, et al. Vaccination with an Attenuated Mutant of Ehrlichia chaffeensis Induces Pathogen-Specific CD4+ T Cell Immunity and Protection from Tick-Transmitted Wild-Type Challenge in the Canine Host. PLoS One. 2016. URL: https://pubmed.ncbi.nlm.nih.gov/26841025/